FIELD: medicine.
SUBSTANCE: invention relates to field of medicine, pharmacology and concerns application of formula compounds using for anthrax treatment.
EFFECT: invention ensures increased treatment efficiency.
26 cl, 88 ex
Title | Year | Author | Number |
---|---|---|---|
OXAZOLIDINONE-QUINOLONE-HYBRID ANTIBIOTICS | 2004 |
|
RU2371443C2 |
HYBRID ANTIBACTERIAL AGENTS OXAZOLIDINONE-QUINOLONE INTENDED FOR PARENTERAL ADMINISTRATION FOR TREATMENT OR PREVENTION OF BACTERIAL DISEASES | 2014 |
|
RU2702364C2 |
COMBINED THERAPEUTIC AGENTS CONTAINING OXAZOLIDINONES-QUINOLONES INTENDED FOR TREATMENT OF BACTERIAL INFECTIONS | 2014 |
|
RU2675847C2 |
INTERMEDIATE PRODUCTS FOR PRODUCING OXAZOLIDINONE AND QUINOLONE DERIVATIVES | 2004 |
|
RU2373203C2 |
ANTIBIOTIC DERIVATIVES OF 2-OXO-OXAZOLIDINE-3, 5-DIYL | 2012 |
|
RU2616609C2 |
VERSIONS OF METHOD OF PRODUCING DERIVATIVES OF 1,8-NAPHTHYRIDINE OR ACID-ADDITIVE SALTS THEREOF | 0 |
|
SU1456015A3 |
BICYCLIC NITROIMIDAZOLES COVALENTLY CONNECTED TO REPLACED PHENYLOXAZOLYDINONES | 2009 |
|
RU2504547C2 |
BICYCLIC KETONES AND METHODS OF THEIR USE | 2018 |
|
RU2797922C2 |
ADAMANTYL DERIVATIVES USEFUL FOR TREATMENT OF JNK-MEDIATED DISORDER | 2012 |
|
RU2626890C2 |
QUINOLONE- AND NAPHTYRIDONE CARBOCYLIC ACID DERIVATIVES AS MIXTURE OF ISOMERS OR INDIVIDUAL ISOMERS AND SALT THEREOF | 1994 |
|
RU2114832C1 |
Authors
Dates
2009-04-10—Published
2004-04-06—Filed